Search results

Selected filters:

News
Patents

Article type

Topic

Sector

Regions

Year

616 results found for your search

Sort options
19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

17 October 2019

All eyes on London with globally-important FRAND appeals set for next week

The UK Supreme Court next week will be the first top court in any jurisdiction to consider the enforcement of SEPs subject to a global FRAND licensing undertaking. SEP holders and licensees will be watching closely

11 October 2019

Data reveals strong growth in the number of female inventors, but there is still a long way to go

A report by the UK IP Office finds more women named on patents than ever before – but also that they remain woefully under-represented. We present the top takeaways from a very timely study

10 October 2019

Patent term adjustments in the US are readjusted, again

Two recent Federal Circuit decisions have shed further light on a highly litigated area of biopharma patent law

08 October 2019

An eyebrow-raising CJEU ruling could be bad news for generics

Europe’s highest court has handed down a surprising decision concerning the consequences of an “unjustified” preliminary injunction issued in a pharma patent case

05 October 2019

The USPTO seeks AI expertise to change the rules of the game internally and externally

New role has the potential to deliver results that will enhance internal processes, improve quality, lower costs and help recover lost US influence in the international IP arena

03 October 2019

For start-ups, patents should be a means to an end, not an end in themselves

Investing in IP may be necessary for early-stage businesses, but there are plenty of circumstances when the money is better spent elsewhere

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

30 September 2019

Europe and Latin America moving to marriage, but IP could be grounds for divorce

The recent trade accord agreed in principle between the EU and Mercosur promises to deliver significant benefits, but political controversies around issues such as data protection and SPCs mean that the deal is not yet sealed

28 September 2019

The US is gifting 5G patent leadership to others

Policy confusion and problematic court decisions mean that the shape of the IP landscape in this pivotal technology is being determined elsewhere

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

17 September 2019

Australia’s harsh approach to software patents set to continue

Observers had hoped Friday’s decision in the Encompass case would clarify key patentability questions. But a Full Bench of the Federal Court of Australia did not take the opportunity to do so

13 September 2019

Patent litigation is one reason why the UK will remain in the legal premier league

Despite the pervading sense of gloom, the quality of English courts and lawyers - and the remedies now available to plaintiffs - mean that there is an IP bright spot amidst the carnage of Brexit

12 September 2019

The Boston Manifesto - why IP needs more women and how to make it happen 

The IP world, particularly in the field of patents, continues to be dominated by men. A group of senior professionals from all parts of the IP ecosystem came together before this year's IPBC in Boston to discuss ways to encourage greater diversity and to produce recommendations to achieve it  

12 September 2019

Huawei CEO: our 5G IP can be had for an upfront fee

Ren Zhengfei welcomes telecom equipment competition with a grandiose offer, but some key details are still open to question